2024. Molecular Characterisation and Therapeutic Implications of FGFR2 Fusions in Tissue and Circulating Tumor DNA from Patients with Intrahepatic Cholangiocarcinoma: A Review. Annals of Gastroenterology and Digestive Disorders. 7, 1 (Aug. 2024), 21–26. DOI:https://doi.org/10.5281/zenodo.22179497.